Thyssenkrupp nucera : Investorenpräsentation Q2/H1 2023/24

With you today

2 15 May 2024 | Q2/6M 2023/24 Results Presentation | thyssenkrupp nucera

Disclaimer

This presentation has been prepared by thyssenkrupp nucera AG & Co. KGaA ("thyssenkrupp nucera") and comprises the written materials/slides for a presentation concerning thyssenkrupp nucera. By attending this presentation and/or reviewing the slides you agree to be bound by the following conditions. The distribution of this document in certain jurisdictions may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.

This presentation is for information purposes only and the information contained herein (unless otherwise indicated) has been provided by thyssenkrupp nucera. It does not constitute an offer to sell or the solicitation, inducement or an offer to buy shares in thyssenkrupp nucera or any other securities. Further, it does not constitute a recommendation by thyssenkrupp nucera or any other party to sell or buy shares in thyssenkrupp nucera or any other securities and should not be treated as giving investment, legal, accounting, regulatory, taxation or other advice. This presentation has been prepared without reference to any particular investment objectives, financial situation, taxation position and particular needs. In case of any doubt in relation to these matters, you should consult your stockbroker, bank manager, legal adviser, accountant, taxation adviser or other independent financial adviser.

The information contained in this presentation has not been independently verified, and no representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information contained herein and no reliance should be placed on it. To the extent permitted by applicable law, none of thyssenkrupp nucera or any of its affiliates, advisers, connected persons or any other person accept any liability for any loss howsoever arising (in negligence or otherwise), directly or indirectly, from this presentation or its contents or otherwise arising in connection with this presentation. No representation or warranty, either express or implied, is provided in relation to the accuracy, completeness or reliability of the information contain herein.

This presentation contains forward-looking statements that are subject to risks and uncertainties. Statements contained herein that are not statements of historical fact may be deemed to be forward-looking information. When we use words such as "plan," "believe," "expect," "anticipate," "intend," "estimate," "may" or similar expressions, we are making forward-looking statements. You should not rely on forward-looking statements because they are subject to a number of assumptions concerning future events, and are subject to a number of uncertainties and other factors, many of which are outside of our control, that could cause actual results to differ materially from those indicated.

Any assumptions, views or opinions (including statements, projections, forecasts or other forward-looking statements) contained in this presentation represent the assumptions, views or opinions of thyssenkrupp nucera as of the date indicated and are subject to change without notice. Thyssenkrupp nucera neither intends, nor assumes any obligation, unless required by law, to update or revise these assumptions, views or opinions in light of developments which differ from those anticipated. All information not separately sourced is from internal company data and estimates. Any data relating to past performance contained herein is no indication as to future performance. The information in this presentation is not intended to predict actual results, and no assurances are given with respect thereto.

This presentation contains certain supplemental financial or operative measures that are not calculated in accordance with IFRS and are therefore considered as non-IFRS measures. We believe that such non-IFRS measures used, when considered in conjunction with (but not in lieu of) other measures that are computed in accordance with IFRS, enhance the understanding of our business, results of operations, financial position or cash flow. There are, however, material limitations associated with the use of non-IFRS measures including (without limitation) the limitations inherent in the determination of relevant adjustments. The non-IFRS measures used by us may differ from, and not be comparable to, similarly titled measures used by other companies.

All numbers shown are as reported, unless otherwise stated. All amounts are stated in million euros (mn €) unless otherwise indicated. Amounts below 0.5mn € are rounded and reported as 0. Rounding differences may occur.

3 15 May 2024 | Q2/6M 2023/24 Results Presentation | thyssenkrupp nucera

4 15 May 2024 | Q2/6M 2023/24 Results Presentation | thyssenkrupp nucera

1. Business update

5 15 May 2024 | Q2/6M 2023/24 Results Presentation | thyssenkrupp nucera

Signed contracts and close customer collaboration in different stages underscore nucera's strong industry positioning and market demand

6 15 May 2024 | Q2/6M 2023/24 Results Presentation | thyssenkrupp nucera

7 15 May 2024 | Q2/6M 2023/24 Results Presentation | thyssenkrupp nucera

Strategic partnership with Fraunhofer IKTS to industrialize SOEC technology

• Strengthening and diversifying of hydrogen technology portfolio for industrial applications through highly innovative high-temperatureelectrolysis (SOEC)

• Investment in the further development and industrialization of the IKTS technology

• Acquisition of license to use technology

• Pilot plant for cell and stack manufacturing to go into operation in Q1 2025

• Design for later production ramp-up depending on results of the pilot production line

The partnership on SOEC technology is the next step in the implementation of nucera's growth strategy.

8 15 May 2024 | Q2/6M 2023/24 Results Presentation | thyssenkrupp nucera

U.S. Department of Energy funding to build integrated gigawatt factory acknowledges nucera's technological leadership

• Selected for a $50 million grant by the U.S. Department of Energy (DoE)

• Purpose of the funding is the mass production of cells and the establishment of an automated AWE assembly line in the U.S.

• Planned collaboration with De Nora to produce multiple gigawatts output p.a. in integrated factory

• Final terms of funding currently negotiated with the DoE for an overall funding period of 3 years

This funding supports nucera's aim to further expand its footprint in the North American hydrogen market.

9 15 May 2024 | Q2/6M 2023/24 Results Presentation | thyssenkrupp nucera